Altered brain connectivity in mild cognitive impairment is linked to elevated tau and phosphorylated tau, but not to GAP-43 and Amyloid-β measurements: a resting-state fMRI study.

Publisher: BioMed Central Country of Publication: England NLM ID: 101468876 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-6606 (Electronic) Linking ISSN: 17566606 NLM ISO Abbreviation: Mol Brain Subsets: MEDLINE

Original Publication: London : BioMed Central

tau Proteins*/metabolism ; tau Proteins*/cerebrospinal fluid ; Cognitive Dysfunction*/physiopathology ; Cognitive Dysfunction*/diagnostic imaging ; Cognitive Dysfunction*/metabolism ; Amyloid beta-Peptides*/metabolism ; Amyloid beta-Peptides*/cerebrospinal fluid ; Brain*/diagnostic imaging ; Brain*/physiopathology ; Brain*/metabolism ; Magnetic Resonance Imaging*/methods ; Rest*/physiology ; GAP-43 Protein*/metabolism; Humans ; Male ; Female ; Aged ; Phosphorylation ; Middle Aged ; Biomarkers/metabolism

Mild Cognitive Impairment (MCI) is a neurological condition characterized by a noticeable decline in cognitive abilities that falls between normal aging and dementia. Along with some biomarkers like GAP-43, Aβ, tau, and P-tau, brain activity and connectivity are ascribed to MCI; however, the link between brain connectivity changes and such biomarkers in MCI is still being investigated. This study explores the relationship between biomarkers like GAP-43, Aβ, tau, and P-tau, and brain connectivity. We enrolled 25 Participants with normal cognitive function and 23 patients with MCI. Levels of GAP-43, Aβ1-42, t-tau, and p-tau181p in the CSF were measured, and functional connectivity measures including ROI-to-voxel (RV) correlations and the DMN RV-ratio were extracted from the resting-state fMRI data. P-values below 0.05 were considered significant. The results showed that in CN individuals, higher connectivity within the both anterior default mode network (aDMN) and posterior DMN (pDMN) was associated with higher levels of the biomarker GAP-43. In contrast, MCI individuals showed significant negative correlations between DMN connectivity and levels of tau and P-tau. Notably, no significant correlations were found between Aβ levels and connectivity measures in either group. These findings suggest that elevated levels of GAP-43 indicate increased functional connectivity in aDMN and pDMN. Conversely, elevated levels of tau and p-tau can disrupt connectivity through various mechanisms. Thus, the accumulation of tau and p-tau can lead to impaired neuronal connectivity, contributing to cognitive decline.
(© 2024. The Author(s).)

Biomedicines. 2022 Sep 19;10(9):. (PMID: 36140422)
Neuron. 2008 Apr 10;58(1):42-51. (PMID: 18400162)
Arch Neurol. 2001 Dec;58(12):1985-92. (PMID: 11735772)
Front Aging Neurosci. 2020 Apr 01;12:77. (PMID: 32296326)
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7657-62. (PMID: 10861025)
J Neurol Sci. 2012 Jan 15;312(1-2):39-44. (PMID: 21893322)
Proteomics Clin Appl. 2016 Dec;10(12):1242-1253. (PMID: 27604409)
Heliyon. 2024 Feb 21;10(5):e26839. (PMID: 38463796)
Cochrane Database Syst Rev. 2015 Mar 05;(3):CD010783. (PMID: 25740785)
Int Psychogeriatr. 2004 Jun;16(2):129-40. (PMID: 15318760)
Front Neurosci. 2018 Oct 23;12:770. (PMID: 30405347)
Ann Clin Transl Neurol. 2021 Jul;8(7):1456-1470. (PMID: 34129723)
Arch Neurol. 2009 Sep;66(9):1151-7. (PMID: 19752306)
Neurology. 2021 Nov 23;97(21):e2065-e2078. (PMID: 34556565)
J Neurosci. 1989 Nov;9(11):3861-9. (PMID: 2531216)
Learn Mem. 2007 Jun 06;14(6):407-15. (PMID: 17554085)
Neurology. 2020 Aug 25;95(8):e953-e961. (PMID: 32586895)
Cortex. 2017 Dec;97:143-159. (PMID: 29102243)
Nat Commun. 2022 Apr 12;13(1):1969. (PMID: 35413950)
Brain Res. 1994 Jun 6;647(2):333-9. (PMID: 7922508)
Front Aging Neurosci. 2023 Jan 09;14:1037347. (PMID: 36698861)
Brain Sci. 2022 Oct 06;12(10):. (PMID: 36291289)
Clin Chem. 2005 Feb;51(2):336-45. (PMID: 15563479)
Front Aging Neurosci. 2021 Sep 01;13:721171. (PMID: 34539382)
Lancet Neurol. 2003 Jan;2(1):15-21. (PMID: 12849297)
J Neurosci. 2005 Aug 24;25(34):7709-17. (PMID: 16120771)
Neurologia. 2012 Jan;27(1):28-33. (PMID: 21621878)
Neuroimage Clin. 2023;40:103533. (PMID: 37952286)
Nat Commun. 2017 Oct 31;8(1):1214. (PMID: 29089479)
Sci Rep. 2019 Sep 27;9(1):13984. (PMID: 31562355)
Front Mol Neurosci. 2020 Sep 30;13:570045. (PMID: 33100967)
Transl Neurodegener. 2021 Nov 10;10(1):45. (PMID: 34753506)
Brain. 2014 Jul;137(Pt 7):2052-64. (PMID: 24771519)
Neuroimage. 2023 Jul 15;275:120146. (PMID: 37127190)
Alzheimers Dement. 2019 Jan;15(1):55-64. (PMID: 30321501)
PLoS One. 2014 Apr 01;9(4):e92325. (PMID: 24691121)
Stroke. 1998 Sep;29(9):1972-80; discussion 1980-1. (PMID: 9731626)
Cell Biochem Funct. 2013 Jul;31(5):400-11. (PMID: 23055398)
Neuroinformatics. 2024 Jul;22(3):239-250. (PMID: 38630411)
Nat Commun. 2020 Jan 17;11(1):347. (PMID: 31953405)
Front Hum Neurosci. 2014 Feb 24;8:74. (PMID: 24605094)
Nitric Oxide. 2023 May 1;134-135:23-37. (PMID: 37019299)
Brain Commun. 2022 Mar 09;4(2):fcac055. (PMID: 35356035)
Dement Geriatr Cogn Disord. 2001 Jul-Aug;12(4):257-64. (PMID: 11351137)
Front Neurosci. 2022 Aug 12;16:951128. (PMID: 36033617)
Front Neurosci. 2017 Mar 31;11:167. (PMID: 28408865)
Aging Clin Exp Res. 2022 Oct;34(10):2399-2406. (PMID: 35988117)
Brain. 2013 Jul;136(Pt 7):2239-52. (PMID: 23801740)
Front Immunol. 2022 Apr 26;13:856376. (PMID: 35558075)
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11606-11. (PMID: 23798398)
Alzheimers Dement (Amst). 2016 Dec 10;5:35-42. (PMID: 28054026)
Neurosci Biobehav Rev. 2009 Mar;33(3):279-96. (PMID: 18824195)
Cell. 1995 Oct 20;83(2):269-78. (PMID: 7585944)
Br J Psychiatry. 2006 Nov;189:399-404. (PMID: 17077428)
Front Aging Neurosci. 2022 Mar 10;14:812664. (PMID: 35360208)
Sci Rep. 2022 Oct 17;12(1):17392. (PMID: 36253408)
Sci Rep. 2017 Jul 26;7(1):6517. (PMID: 28747760)
Behav Sci (Basel). 2024 Apr 22;14(4):. (PMID: 38667145)
Acta Neuropathol. 1994;88(6):553-7. (PMID: 7879602)
J Neurosci. 2017 Sep 13;37(37):8857-8859. (PMID: 28904212)
Brain Res Bull. 2023 Oct 15;203:110777. (PMID: 37813312)
Neurobiol Aging. 2006 Feb;27(2):237-44. (PMID: 16399209)
J Biol Chem. 1992 May 5;267(13):9059-64. (PMID: 1533624)
Neurosci Lett. 1998 Oct 16;255(2):83-6. (PMID: 9835220)
Age Ageing. 2022 Aug 2;51(8):. (PMID: 35977150)
Front Cell Neurosci. 2017 Aug 31;11:266. (PMID: 28912688)
J Neuroinflammation. 2023 Jul 14;20(1):165. (PMID: 37452321)
Nat Med. 2023 Jul;29(7):1775-1781. (PMID: 37248300)
Neuron. 2003 Mar 27;37(6):925-37. (PMID: 12670422)
Sci Rep. 2017 Dec 18;7(1):17702. (PMID: 29255203)
Cells. 2022 Dec 21;12(1):. (PMID: 36611808)
J Neurosci. 2017 Apr 19;37(16):4323-4331. (PMID: 28314821)
Alzheimers Res Ther. 2024 Apr 12;16(1):81. (PMID: 38610055)
Signal Transduct Target Ther. 2023 Jul 12;8(1):267. (PMID: 37433768)
Neurosci Lett. 2015 Jun 15;597:176-82. (PMID: 25929184)
Brain Commun. 2022 Feb 07;4(1):fcac016. (PMID: 35233522)
Sci Rep. 2016 Feb 12;6:21001. (PMID: 26867499)
J Am Geriatr Soc. 1992 Sep;40(9):922-35. (PMID: 1512391)
Neurobiol Aging. 2020 Aug;92:141-152. (PMID: 32280029)
J Neurobiol. 1992 Jul;23(5):507-20. (PMID: 1431834)
Brain. 2018 Feb 1;141(2):568-581. (PMID: 29315361)
Nat Commun. 2020 May 26;11(1):2612. (PMID: 32457389)
Neurosci Lett. 1993 Nov 12;162(1-2):51-4. (PMID: 8121636)
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10824-9. (PMID: 23754371)
Curr Neuropharmacol. 2006 Oct;4(4):293-304. (PMID: 18654638)
Nat Commun. 2024 Jan 3;15(1):202. (PMID: 38172114)
Int Psychogeriatr. 2013 Oct;25(10):1667-77. (PMID: 23866942)
Neurology. 2023 Jan 17;100(3):e275-e285. (PMID: 36192174)
Neurobiol Dis. 2013 Feb;50:127-34. (PMID: 23064434)
Neuron. 2009 Jul 30;63(2):178-88. (PMID: 19640477)

Keywords: Amyloid β; Brain connectivity; Default mode network; GAP-43; Mild cognitive impairment; Tau protein

0 (tau Proteins)
0 (Amyloid beta-Peptides)
0 (GAP-43 Protein)
0 (Biomarkers)

Date Created: 20240830 Date Completed: 20240831 Latest Revision: 20240904

20250114

PMC11363600

10.1186/s13041-024-01136-z

39215335